RX-5902

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameRX-5902
Drug Alias NameSupinoxinRX-5902
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionATP-dependent RNA helicase DDX3X inhibitorsATP-dependent RNA helicase DDX1 inhibitors
TargetsATP-dependent RNA helicase DDX1ATP-dependent RNA helicase DDX3X
Therapy Area/IndicationsSolid tumoursTriple Negative Breast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesRexahn Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRexahn Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsSolid tumoursTriple Negative Breast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A